Identification of Clinically Significant Portal Hypertension in cACLD Individuals With Spleen Stiffness Measurement
Liver International · 2025
DOI: 10.1111/liv.16241 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Liver International, 2025. Verfasst von Xiaofeng Zhang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Elasticity Imaging Techniques, Hypertension, Portal, Spleen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: National Science and Technology Major Project, National Natural Science Foundation of China, Clinical Research Program of Nanfang Hospital, Southern Medical University.
Abstract (Originalsprache)
Background and Aims The Baveno VII consensus recommends spleen stiffness measurement (SSM) for the detection of clinically significant portal hypertension (CSPH) in patients with compensated advanced chronic liver disease (cACLD). We aimed to evaluate the performance of SSM‐based algorithms.
Methods
Consecutive cACLD individuals who underwent hepatic venous pressure gradient measurement, liver stiffness measurement (LSM), and SSM measured with the dedicated 100‐Hz probe by vibration‐controlled transient elastography were prospectively enrolled.
Results
From July 2021 to August 2024, a total of 395 patients were screened, and 185 cACLD cases were enrolled, of which 101 patients had CSPH. An SSM > 50 kPa demonstrated a positive predictive value (PPV) of 98.0% and a specificity of 98.8% for ruling in CSPH, correctly identifying 47.5% (48/101) of CSPH cases. Sensitivity analysis revealed that in 60 patients with aetiology removal or suppression, SSM > 50 kPa achieved both a PPV and specificity of 100%. Among the 125 patients with ongoing aetiologies, the PPV and specificity were 96.4% and 98.3%, respectively. Across HBV (with or without viral suppression) and non‐HBV subgroups, the PPV and specificity consistently exceeded 90%. In decision curve analysis, SSM > 50 kPa provided the highest net benefit compared with other elastography‐based algorithms when threshold probabilities exceeded 0.8.
Conclusions
We prospectively validated that SSM > 50 kPa, measured using the spleen‐dedicated probe, is sufficient for identifying CSPH in individuals with cACLD. Trial Registration NCT04820166
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- Department of Hepatology, Zengcheng Branch, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- Department of Infectious Diseases, Shenzhen People's Hospital, The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen, China.
- Department of Gastroenterology, The First Affiliated Hospital of Chengdu Medical College, Chengdu, China.
- Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong, China.
- State Key Laboratory of Digestive Disease, Chinese University of Hong Kong, Hong Kong, China.
ORCID-Profile: Xiaofeng Zhang, Wenfan Luo, Jinjun Chen
Förderung
- National Science and Technology Major Project
- National Natural Science Foundation of China
- Clinical Research Program of Nanfang Hospital, Southern Medical University
- Clinical Research Startup Program of Southern Medical University by High-level University Construction Funding of Guangdong Provincial Department of Education
- Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program
Zitieren
APA
Zhang, X., Zhou, L., Liang, W., Cheng, X., He, Q., Li, H., Luo, W., Huang, J., Li, J., Wang, W., Tu, M., Wang, H., Ou, P., Wen, B., Xiao, L., Zhou, D., Wong, V. W., & Chen, J. (2025). Identification of Clinically Significant Portal Hypertension in cACLD Individuals With Spleen Stiffness Measurement. Liver International. https://doi.org/10.1111/liv.16241
Vancouver
Zhang X, Zhou L, Liang W, Cheng X, He Q, Li H, et al. Identification of Clinically Significant Portal Hypertension in cACLD Individuals With Spleen Stiffness Measurement. Liver International. 2025. doi:10.1111/liv.16241
BibTeX
@article{Zhang2025,
author = {Zhang, Xiaofeng and Zhou, Ling and Liang, Weihao and Cheng, Xiao and He, Qinjun and Li, Hui and Luo, Wenfan and Huang, Jing and Li, Junying and Wang, Weibin and Tu, Minghan and Wang, Haiyu and Ou, Pengcheng and Wen, Biao and Xiao, Lushan and Zhou, Damei and Wong, Vincent Wai-Sun and Chen, Jinjun},
title = {Identification of Clinically Significant Portal Hypertension in cACLD Individuals With Spleen Stiffness Measurement},
journal = {Liver International},
year = {2025},
doi = {10.1111/liv.16241}
}
EUVIMED